WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 24, 2015, to discuss ImmunoGen's financial results for the three-month period ended March 31, 2015, the third quarter of its 2015 fiscal year. Management will also provide an update on the Company and the financial guidance.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
